A team at the University of Chicago is reimagining diagnostics with an unexpected material—air. Their invention, called ABLE (Airborne Biomarker Localization Engine), does something astonishingly simple yet revolutionary: it turns breath into liquid. Not metaphorically, but quite literally.

The Problem with Blood

There’s a reason why blood dominates diagnostics: it’s rich with molecular information. Glucose levels, hormones, antibodies, inflammatory markers—all float conveniently in our veins. Yet extracting that data involves discomfort, infrastructure, and time.

For newborns in neonatal intensive care, for instance, even a tiny blood draw can be a significant medical event. And for diabetics, frequent finger sticks are just part of daily life.

While non-invasive sensors have gained traction, most—like pulse oximeters or smartwatches—focus on surface-level vitals. Going deeper has always meant going under the skin. Until now.

Here’s the catch: air isn’t dense. Molecules in your breath are scattered—millions of times more diluted than in blood. Detecting them reliably has long required bulky lab equipment like mass spectrometers. That’s hardly feasible at your bedside or in a public restroom.

ABLE sidesteps this entirely by condensing the air into droplets, effectively “squeezing” those sparse molecules into a form that can be analyzed with standard liquid-based tools. It’s like collecting morning dew and finding in it the secrets of your metabolism.

The device contains a pump, a humidifier, and a tiny refrigeration unit. These components work together to cool humidified air rapidly, forming droplets that slide down a silicon-spiked surface. The result? A miniature vial of your breath, ready for analysis.

How ABLE Works in Real Life

In one quirky early test, lead researcher Jingcheng Ma blew vaporized coffee into the device. Not only did it work—the scent of coffee lingered in the condensed liquid—it also confirmed ABLE’s ability to capture volatile molecules. That paved the way for medical tests involving more complex molecules like glucose, markers of bacterial infection, and even signs of inflammation related to gut health.

In hospitals, ABLE could be a game-changer. Imagine detecting airborne pathogens in waiting rooms before they cause outbreaks. Or checking an infant’s health via breath instead of blood. It’s already been shown to capture signs of E. coli and inflammation in animal studies.

The device’s core innovation—its slippery condensation surface—isn’t entirely man-made.

It draws inspiration from organisms that have mastered water collection, like desert beetles that pull moisture from thin fog, or lotus leaves that remain dry despite constant contact with water. Their secret lies in super hydrophobic textures—tiny ridges and valleys that repel water.

The ABLE team mimicked this strategy using microscopic silicon spikes, about 1/200th the width of a human hair. This design doesn’t just help collect droplets; it helps preserve the integrity of the biomarkers within them. Think of it as designing a racetrack for molecules, with no puddles or potholes to interfere.

The Road Ahead: Smaller, Smarter, and Everywhere

While today’s ABLE device is portable, the goal is wearability. A miniaturized version could monitor your health as passively as a fitness tracker, checking for early signs of respiratory infections, inflammation, or even metabolic changes—all by simply breathing.

Researchers also plan to expand its capabilities beyond healthcare. Food spoilage detection, pollution tracking, even biosecurity at airports could benefit from this tech.

Yet challenges remain. Current models still capture only a fraction of ambient moisture, and the water-repelling coating may degrade over time. But as with any transformative tool, refinement is part of the journey.

[Source: 1,2]

The post University of Chicago’s New Device Could Replace Needles in Medical Diagnostics appeared first on Medical Journal Daily.